Jeffrey Popma, MD, is the Chief Scientific and Strategic Officer at the Cardiovascular Research Foundation. A world-renowned leader in cardiovascular research, his work focuses on advancing CRF’s educational and research initiatives, including publications, real-world data analytics, clinical trial metrics, and Core Lab activities. He also serves as a Program Director for New York Valves and TCT (Transcatheter Cardiovascular Therapeutics), CRF’s annual scientific symposium.
With decades of clinical and research experience, Dr. Popma has made significant contributions to cardiovascular therapies and minimally invasive cardiac interventions. Over the course of his career, he has authored more than 500 peer-reviewed manuscripts, further advancing the field. He played a pivotal role as a course director during TCT's formative years and served as Director of CRF’s Angiographic Core Laboratory. He returns to CRF after positions as Director, Interventional Cardiology at the Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center in Boston. Most recently, Dr. Popma was the Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart at Medtronic.
Dr. Popma is a Professor of Medicine, Emeritus, Harvard Medical School in Boston. He is a former Past President of the Society for Cardiovascular Angiography and Intervention (SCAI) and former Co-Chairman of the Interventional Council at the American College of Cardiology (ACC). Dr. Popma received his bachelor’s in economics from Stanford University, and his medical degree summa cum laude from the Indiana University School of Medicine.